Research & Development

ProductInterveXion’s anti-METH therapies work by preventing the abused drug from rapidly reaching the brain in large quantities. These therapies involve antibodies that can “absorb” METH in the blood to block their rewarding effects and simultaneously reduce their detrimental health effects. In addition to reducing the acute effects of overdose, these antibodies may also be used in the chronic setting to help abusers overcome their dependency.